Digoxin 0.05mg; per mL; lime-flavored; contains alcohol 10%. Renal dysfunction: reduce dose. Sinus node disease. Incomplete AV block. Accessory AV pathway (Wolff-Parkinson-White syndrome). Heart ...
Hosted on MSN29d
Proof-of-concept study dissolves clusters of breast cancer cells to prevent metastasesthe researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters. The ETH spin-off, Page Therapeutics, is already working on this solution.
Heart failure (HF) is the leading cause of hospitalization among older adults. Digoxin has been shown to reduce hospitalization due to worsening HF. However, at the commonly prescribed dose of 0. ...
the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters. The ETH spin-off, Page Therapeutics is already working on this solution.
the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters. The ETH spin-off, Page Therapeutics is already working on this solution.
Digoxin is used extensively in combination with other medications in the treatment of heart failure, and is often prescribed to patients with atrial fibrillation — a kind of irregular heartbeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback